Complete hematological and major molecular response through treatment with low‐dose Interferon alpha 2a in high‐risk polycythemia vera patient: a case report

Abstract Low‐dose interferon‐α 2a treatment may be considered as an alternative to cytoreductive therapy with hydroxyurea or regularly dosed interferon in high‐risk polycythemia vera patients.

Guardado en:

Detalles Bibliográficos
Autores principales:	Christoph Driessen, Christoph Noppen, Georg Boonen, Juergen Drewe
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	interferon low dose polycythemia vera Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/5c0ee879362c4452a3469335c3c0f0a6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5c0ee879362c4452a3469335c3c0f0a6
record_format	dspace
spelling	oai:doaj.org-article:5c0ee879362c4452a3469335c3c0f0a62021-12-02T07:55:56ZComplete hematological and major molecular response through treatment with low‐dose Interferon alpha 2a in high‐risk polycythemia vera patient: a case report2050-090410.1002/ccr3.4903https://doaj.org/article/5c0ee879362c4452a3469335c3c0f0a62021-10-01T00:00:00Zhttps://doi.org/10.1002/ccr3.4903https://doaj.org/toc/2050-0904Abstract Low‐dose interferon‐α 2a treatment may be considered as an alternative to cytoreductive therapy with hydroxyurea or regularly dosed interferon in high‐risk polycythemia vera patients.Christoph DriessenChristoph NoppenGeorg BoonenJuergen DreweWileyarticleinterferonlow dosepolycythemia veraMedicineRMedicine (General)R5-920ENClinical Case Reports, Vol 9, Iss 10, Pp n/a-n/a (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	interferon low dose polycythemia vera Medicine R Medicine (General) R5-920
spellingShingle	interferon low dose polycythemia vera Medicine R Medicine (General) R5-920 Christoph Driessen Christoph Noppen Georg Boonen Juergen Drewe Complete hematological and major molecular response through treatment with low‐dose Interferon alpha 2a in high‐risk polycythemia vera patient: a case report
description	Abstract Low‐dose interferon‐α 2a treatment may be considered as an alternative to cytoreductive therapy with hydroxyurea or regularly dosed interferon in high‐risk polycythemia vera patients.
format	article
author	Christoph Driessen Christoph Noppen Georg Boonen Juergen Drewe
author_facet	Christoph Driessen Christoph Noppen Georg Boonen Juergen Drewe
author_sort	Christoph Driessen
title	Complete hematological and major molecular response through treatment with low‐dose Interferon alpha 2a in high‐risk polycythemia vera patient: a case report
title_short	Complete hematological and major molecular response through treatment with low‐dose Interferon alpha 2a in high‐risk polycythemia vera patient: a case report
title_full	Complete hematological and major molecular response through treatment with low‐dose Interferon alpha 2a in high‐risk polycythemia vera patient: a case report
title_fullStr	Complete hematological and major molecular response through treatment with low‐dose Interferon alpha 2a in high‐risk polycythemia vera patient: a case report
title_full_unstemmed	Complete hematological and major molecular response through treatment with low‐dose Interferon alpha 2a in high‐risk polycythemia vera patient: a case report
title_sort	complete hematological and major molecular response through treatment with low‐dose interferon alpha 2a in high‐risk polycythemia vera patient: a case report
publisher	Wiley
publishDate	2021
url	https://doaj.org/article/5c0ee879362c4452a3469335c3c0f0a6
work_keys_str_mv	AT christophdriessen completehematologicalandmajormolecularresponsethroughtreatmentwithlowdoseinterferonalpha2ainhighriskpolycythemiaverapatientacasereport AT christophnoppen completehematologicalandmajormolecularresponsethroughtreatmentwithlowdoseinterferonalpha2ainhighriskpolycythemiaverapatientacasereport AT georgboonen completehematologicalandmajormolecularresponsethroughtreatmentwithlowdoseinterferonalpha2ainhighriskpolycythemiaverapatientacasereport AT juergendrewe completehematologicalandmajormolecularresponsethroughtreatmentwithlowdoseinterferonalpha2ainhighriskpolycythemiaverapatientacasereport
_version_	1718399104370868224

Complete hematological and major molecular response through treatment with low‐dose Interferon alpha 2a in high‐risk polycythemia vera patient: a case report

Ejemplares similares